US 10675302
Methods and compositions for targeted cleavage and recombination
granted A61KA61K2035/124A61K35/12
Quick answer
US patent 10675302 (Methods and compositions for targeted cleavage and recombination) held by Sangamo Therapeutics, Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2035/124, A61K35/12